Status:
COMPLETED
Tap Block vs Conventional Pain Medication for Patients Undergoing Robotic Sacrocolpopexy
Lead Sponsor:
ProMedica Health System
Conditions:
Anesthesia, Local
Prolapse
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to assess whether the transversus abdominis plane block (Tap block) is different than the oral postoperative pain medications in controlling pain after robotic sacrocolpop...
Detailed Description
Sacrocolpopexy is a procedure to correct prolapse of the vaginal apex (top of the vagina) in women who have had a previous hysterectomy. The operation is designed to restore the vagina to its normal p...
Eligibility Criteria
Inclusion
- Adults 18 years of age or older
- Planning for surgical treatment of Pelvic Organ Prolapse (POP) with robotic sacrocolpopexy and rectocele repair under general anesthesia
- Patient undergoing concurrent hysterectomy and/or sub-urethral sling will be included
Exclusion
- Pregnant or nursing
- Allergy to ropivicaine
- History of drug/alcohol abuse
- Severe cardiovascular, hepatic, renal disease, or neurological impairment Long-acting opioid use within 3 days or any opioid use within 24 hours before surgery
- Contraindication to: acetaminophen, tramadol, non-steroidal anti- inflammatory drugs (NSAID)
- Administration of an investigational drug within 30 days before study
- Chronic pain syndromes
- Daily NSAID/opioid use
- Patients not undergoing general anesthesia
- Patients undergoing concurrent transvaginal mesh removal, anal sphincteroplasty, or fistula repair
Key Trial Info
Start Date :
June 28 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04440475
Start Date
June 28 2020
End Date
January 30 2022
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Promedica Toledo Hospital
Toledo, Ohio, United States, 43606